Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion type Assertion NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_head.
- NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_provenance.
- NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion evidence source_evidence_literature NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_provenance.
- NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion SIO_000772 14583450 NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_provenance.
- NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion wasDerivedFrom befree-20140225 NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_provenance.
- NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion wasGeneratedBy ECO_0000203 NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_provenance.